Free Trial

Relmada Therapeutics (RLMD) Institutional Ownership

Relmada Therapeutics logo
$4.21 +0.05 (+1.20%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$4.22 +0.00 (+0.12%)
As of 11/13/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Relmada Therapeutics (NASDAQ:RLMD)

Current
Institutional Ownership
Percentage
45.24%
Number of
Institutional Buyers
(last 12 months)
62
Total
Institutional Inflows
(last 12 months)
$460.52M
Number of
Institutional Sellers
(last 12 months)
8
Total
Institutional Outflows
(last 12 months)
$14.01M
Get RLMD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Relmada Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

RLMD Institutional Buying and Selling by Quarter

Relmada Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/14/2026Marshall Wace LLP603,357$2.28M0.0%-73.1%0.566%
11/13/2026HighVista Strategies LLC419,299$1.58M0.4%-5.9%0.393%
11/12/2026 State Street Corp3,309,355$12.48M0.0%-34.3%3.102%
11/6/2026 Russell Investments Group Ltd.165,861$625K0.0%+2,093.3%0.155%
11/3/2026 Alps Advisors Inc.140,319$529K0.0%+31.8%0.132%
10/29/2026 Profund Advisors LLC195,555$737K0.0%+615.6%0.183%
8/21/2026 AXQ Capital LP12,093$84K0.0%N/A0.011%
8/19/2026Wellington Management Group LLP63,800$441K0.0%N/A0.060%
8/17/2026Seven Fleet Capital Management LP348,265$2.41M0.4%N/A0.326%
8/17/2026Corient Private Wealth LP719,582$4.93M0.0%N/A0.675%
8/17/2026Bank of America Corp DE812,059$5.62M0.0%N/A0.761%
8/15/2026Jupiter Topco LLC11,164,803$77.32M0.0%N/A10.467%
8/14/2026ADAR1 Capital Management LLC451,918$3.13M0.1%N/A0.424%
8/14/2026Legal & General Group Plc9,181$64K0.0%N/A0.009%
8/14/2026The Manufacturers Life Insurance Company25,027$173K0.0%N/A0.023%
8/14/2026Spruce Street Capital LP6,391,328$44.23M0.0%N/A5.992%
8/12/2026 X Square Capital LLC100,000$692K0.2%N/A0.094%
8/12/2026 Keebeck Wealth Management13,000$90K0.0%N/A0.012%
8/7/2026BlackRock Inc.7,426,780$51.39M0.0%N/A7.081%
8/7/2026 Deutsche Bank AG318,902$2.21M0.0%N/A0.304%
8/7/2026Persistent Asset Partners Ltd86,443$598K0.2%N/A0.082%
8/6/2026 Bank of New York Mellon Corp295,623$2.05M0.0%N/A0.282%
8/6/2026 State of Wyoming20,586$142K0.0%N/A0.020%
8/6/2026GSA Capital Partners LLP141,443$979K0.1%N/A0.135%
8/3/2026Walleye Capital LLC616,238$4.26M0.0%N/A0.588%
5/19/2026Bank of America Corp DE125,941$877K0.0%+397.0%0.120%
5/19/2026Stempoint Capital LP597,409$4.16M0.8%N/A0.570%
5/19/2026RBF Capital LLC120,000$835K0.0%-14.3%0.114%
5/19/2026Janus Henderson Group PLC11,063,862$76.89M0.0%+52.2%10.548%
5/19/2026Ally Bridge Group NY LLC210,525$1.47M1.2%N/A0.201%
5/18/2026ADAR1 Capital Management LLC451,918$3.15M0.2%+1,364.1%0.431%
5/18/2026Eversept Partners LP277,899$1.93M0.1%N/A0.265%
5/16/2026Orbimed Advisors LLC4,715,864$32.82M0.6%+80.6%4.496%
5/15/2026Commodore Capital LP633,901$4.41M0.3%N/A0.604%
5/15/2026OMERS ADMINISTRATION Corp41,600$290K0.0%-36.9%0.040%
5/15/2026Spruce Street Capital LP6,262,114$43.00M10.4%+53.3%5.970%
5/14/2026 Renaissance Technologies LLC167,200$1.16M0.0%-9.6%0.159%
5/14/2026Pale Fire Capital SE31,650$220K0.0%-29.0%0.030%
5/14/2026 Keebeck Wealth Management13,000$90K0.0%N/A0.012%
5/14/2026 Knott David M Jr439,300$3.06M1.8%N/A0.419%
Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel

See the five stocks Weiss Ratings analysts are watching closely now.
5/14/2026Bank of Nova Scotia30,600$213K0.0%N/A0.029%
5/14/2026 Sei Investments Co.166,614$1.16M0.0%+68.4%0.159%
5/14/2026 State of Wyoming12,581$88K0.0%N/A0.012%
5/5/2026 Hillsdale Investment Management Inc.53,600$373K0.0%N/A0.051%
4/28/2026 AdvisorShares Investments LLC295,872$2.06M0.4%-7.4%0.282%
3/9/2026Corient Private Wealth LLC719,582$3.44M0.0%+248.2%0.981%
2/26/2026Seven Fleet Capital Management LP154,109$744K0.6%N/A0.210%
2/23/2026Virtu Financial LLC17,640$85K0.0%N/A0.024%
2/19/2026Corient Private Wealth LLC719,582$3.44M0.0%+248.2%0.981%
2/18/2026XTX Topco Ltd41,293$199K0.0%N/A0.056%
2/18/2026Ikarian Capital LLC3,068,359$14.82M1.1%+66.5%4.184%
2/18/2026Squadron Capital Management LLC6,700,000$32.36M13.7%N/A9.137%
2/18/2026Quadrature Capital Ltd53,444$258K0.0%N/A0.073%
2/18/2026Orbimed Advisors LLC2,610,600$12.61M0.3%N/A3.560%
2/18/2026Opaleye Management Inc.935,000$4.52M0.6%N/A1.275%
2/18/2026Millennium Management LLC1,673,017$8.08M0.0%N/A2.281%
2/18/2026Janus Henderson Group PLC7,270,000$35.04M0.0%N/A9.914%
2/18/2026Balyasny Asset Management L.P.547,854$2.65M0.0%N/A0.747%
2/18/2026Boothbay Fund Management LLC835,300$4.03M0.1%+20.5%1.139%
2/17/2026ADAR1 Capital Management LLC30,866$149K0.0%N/A0.042%
2/17/2026Schonfeld Strategic Advisors LLC13,216$64K0.0%N/A0.018%
2/17/2026Braidwell LP1,582,257$7.64M0.2%N/A2.158%
2/17/2026Adage Capital Partners GP L.L.C.4,270,000$20.62M0.0%N/A5.823%
2/17/2026Diadema Partners LP389,395$1.88M0.3%N/A0.531%
2/17/2026ExodusPoint Capital Management LP68,883$333K0.0%N/A0.094%
2/17/2026Mangrove Partners IM LLC27,380$132K0.0%N/A0.037%
2/17/2026Graham Capital Management L.P.25,608$124K0.0%N/A0.035%
2/17/2026Persistent Asset Partners Ltd231,123$1.12M0.5%N/A0.315%
2/17/2026RBF Capital LLC140,000$676K0.0%-14.2%0.191%
2/16/2026 Squarepoint Ops LLC138,233$668K0.0%N/A0.189%
2/16/2026OMERS ADMINISTRATION Corp65,900$318K0.0%N/A0.090%
2/16/2026Spruce Street Capital LP4,086,181$19.74M6.5%N/A5.572%
2/16/2026 Barclays PLC60,000$290K0.0%+500.0%0.082%
2/13/2026Marshall Wace LLP3,189,662$15.41M0.0%+1,072.4%4.350%
2/13/2026Hudson Bay Capital Management LP26,247$127K0.0%N/A0.036%
2/13/2026Charles Schwab Investment Management Inc.53,081$256K0.0%N/A0.072%
2/13/2026 State Street Corp320,820$1.55M0.0%+215.1%0.438%
2/12/2026 Renaissance Technologies LLC185,000$894K0.0%+9.0%0.252%
2/12/2026Informed Momentum Co LLC162,552$785K0.1%N/A0.222%
2/10/2026 AdvisorShares Investments LLC319,510$1.54M0.3%-20.8%0.436%
2/9/2026 Geode Capital Management LLC854,932$4.13M0.0%+188.6%1.166%
2/9/2026Jefferies Financial Group Inc.21,655$105K0.0%N/A0.030%
1/13/2026 Parsons Capital Management Inc. RI263,000$1.27M0.1%+61.0%0.359%
11/17/2025Boothbay Fund Management LLC693,236$1.39M0.0%N/A2.089%
11/14/2025Two Sigma Investments LP173,614$349K0.0%+82.0%0.523%
11/13/2025 Tortoise Investment Management LLC13,909$28K0.0%-35.8%0.042%
11/5/2025 AdvisorShares Investments LLC403,488$811K0.1%+1.8%1.216%
9/26/2025Corient Private Wealth LLC206,667$120K0.0%N/A0.623%
8/15/2025Corient Private Wealth LLC206,667$120K0.0%N/A0.623%
8/15/2025LMR Partners LLP55,104$33K0.0%N/A0.166%
I'm handing you this one free (Ad)

Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel

See today's free stock pick before the December 8th deadline here
8/14/2025 Jane Street Group LLC114,354$69K0.0%N/A0.345%
8/13/2025Marshall Wace LLP154,568$93K0.0%N/A0.466%
8/12/2025XTX Topco Ltd46,039$28K0.0%N/A0.139%
8/4/2025 AdvisorShares Investments LLC396,514$238K0.0%+43.4%1.195%
6/27/2025Goldman Sachs Group Inc.120,852$33K0.0%N/A0.364%
5/16/2025Goldman Sachs Group Inc.120,852$33K0.0%N/A0.364%
2/17/2025Two Sigma Investments LP127,579$66K0.0%-33.3%0.423%
2/17/2025Two Sigma Advisers LP198,900$103K0.0%-18.0%0.659%
2/17/2025Tang Capital Management LLC200,825$104K0.0%+295.1%0.666%
2/17/2025Bridgeway Capital Management LLC72,600$38K0.0%-59.9%0.241%


RLMD Institutional Ownership - Frequently Asked Questions

During the previous two years, 78 institutional investors and hedge funds held shares of Relmada Therapeutics. The most heavily invested institutionals were Jupiter Topco LLC ($77.32M), Janus Henderson Group PLC ($76.89M), BlackRock Inc. ($51.39M), Spruce Street Capital LP ($44.23M), Orbimed Advisors LLC ($32.82M), Squadron Capital Management LLC ($32.36M), and Adage Capital Partners GP L.L.C. ($20.62M).Learn more on Relmada Therapeutics' institutional investors.

45.24% of Relmada Therapeutics' stock is owned by institutional investors. Learn more on RLMD's institutional investor holdings.

Of the 70 institutional investors that purchased Relmada Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Spruce Street Capital LP ($12.65M), Jupiter Topco LLC ($11.16M), Janus Henderson Group PLC ($11.06M), BlackRock Inc. ($7.43M), Squadron Capital Management LLC ($6.70M), Orbimed Advisors LLC ($4.72M), and Adage Capital Partners GP L.L.C. ($4.27M).

Institutional investors have bought a total of 78,452,891 shares in the last 24 months. This purchase volume represents approximately $460.52M in transactions.

The following institutional investors have sold Relmada Therapeutics stock in the last 24 months: State Street Corp ($1.73M), Marshall Wace LLP ($1.64M), AdvisorShares Investments LLC ($107.62K), RBF Capital LLC ($43.26K), HighVista Strategies LLC ($26.50K), OMERS ADMINISTRATION Corp ($24.30K), and Renaissance Technologies LLC ($17.80K).

Institutional investors have sold a total of 3,601,604 shares in the last 24 months. This volume of shares sold represents approximately $14.01M in transactions.



Institutional ownership data for NASDAQ:RLMD is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 11/14/2026. New 13F filings are added each quarter as they're published.
From Our Partners